On October 15, the United States Court of Appeals for the Federal Circuit (CAFC), in St. Jude Medical, LLC v. Snyders Heart Valve LLC, affirmed an inter partes review (IPR) decision of the United States Patent and Trademark Office (USPTO) Patent Trial and Appeal Board (the Board) rejecting St. Jude Medical, LLC’s (St. Jude) contention that Snyders Heart Valve LLC’s (Snyders) artificial heart valve patent was invalid. The CAFC also reviewed a second IPR decision, wherein it reversed the Board’s decision that certain claims of the patent were invalid and affirmed the Board’s decision that the remaining claims were valid.
Litigation
- Judge Lucy Koh Tapped for Ninth Circuit Alongside Seven Other Biden Nominees to Federal Bench
- O’Malley Splits from Majority in CAFC Denial of Mandamus to Stop IPR Institution on Patents Subject to Arbitration
- U.S. District Court Holds that AI Algorithms Cannot Be Listed as Inventors on Patents
- Patent Damages Laws Regarding Apportionment are Inapplicable to Breach of Contract (FRAND) Claims
- CAFC: TTAB Never Had a Pre-Arthrex Appointments Clause Issue
Recent Posts
- IPWatchdog LIVE Event Wraps Up with Featured Speakers Makan Delrahim and Vishal Amin
- Iancu, Kilbride, Israel Separate Fact from Fiction During IPWatchdog LIVE Panel on TRIPS IP Waiver
- Qualcomm’s Mark Snyder Headlines IPWatchdog LIVE Day 2: ‘The U.S. Needs a New Innovation Policy’
- Tillis and Leahy Urge USPTO to Address Inconsistent Prior Art Statements by Patent Applicants at the FDA
- Report: Almost One-Third of IPR Proceedings are Settled